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Abstract 
Improving outcomes in very small children is a major goal of pediatric liver 
transplantation. This report describes our experience of living related liver 
transplantation in an infant weighing 3.98 kg. The recipient, a 80-day-old male infant 
with congenital biliary atresia, was treated with living donor liver transplantation and 
then followed up for 6 months. The left lateral segment (segment II, III) with reduced size 
from the donor, his 26-year-old mother, was used as the graft. The graft weighed 200 g. 
The graft weight to recipient body weight ratio was 5.025%. The donor regained her liver 
function within 3 days and was discharged on day 8. The patient showed good results. 
Liver function returned to normal 9 days after the operation with bilirubin level almost 
decreased to normal. Cyclosporin, mycophenolate mofetil and prednisone were used for 
postoperative immunosuppression. No bleeding, thrombosis, infection or bile leakage 
occurred. The patient had slight fever because of a little collection in the abdomen and 
recovered after paracentesis and drainage. He was discharged on day 16. The donor and 
recipient are in satisfactory condition at present. Improvement of technique in hepatic 
surgery, microsurgical technique in vascular surgery and postoperative intensive care are 
the keys to ensure the success of the procedure. 
Introduction 
Biliary atresia is the most common cause of chronic cholestasis in infants and children. 
The incidence of biliary atresia in infants is estimated at 3.7:10,000 and Kasai 
hepatoportoenterostomy helps these pediatric patients survive beyond infancy. Liver 
transplantation is indicated when the Kasai procedure fails to work or when patients  
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develop progressive deterioration of liver function [1]. In 1967, Starzl performed the first 
liver transplantation in a pediatric patient [2]. However, liver transplantation in young 
infants under the age of 1 year and children with a body weight below 13 kg had a high 
risk of morbidity and mortality and so were initially contraindicated. Additionally, 
because of the small size of the patients, grafts were difficult to obtain. Living donor liver 
transplantation was developed to alleviate organ shortage from deceased donors [3]. With 
advances in surgical technique, liver reduction, reduced-size liver transplantation 
extended liver transplantation to small infants. Now liver transplantation is accepted as an 
established treatment for children with acute and chronic liver failure, especially for 
biliary atresia. In many series, the risk of postoperative complications and rates of 
retransplantation are higher in children less than 1 year old [4]. Goss et al. [5] 
demonstrated that before 1993 one-year survival in patients under 1 year old was 64%, 
while one-year survival increased to 84% after 1994. Little data exist exclusively on very 
young or very small infants (less than 3 months old or <5 kg) who have undergone liver 
transplantation [3]. This report describes our experience with fully performing a living 
related liver transplantation technically more difficult for a 3-month-old infant weighing 
3.98 kg with genital biliary atresia. 
Methods 
The Recipent 
An 80-day-old male child born of a nonconsanguineous marriage presented with abdominal 
distension since 1 month of age. Jaundice, highly colored urine and clay-colored stools were noticed 
since birth. There was no family history of a similar disorder. When admitted to our hospital, he was 
jaundiced with marked splenomegaly. At the time of referral, the child was 51 cm in height, weighed 
3.98 kg and had a temperature of 37.5°C, jaundice, abdominal distension and moderate 
hepatosplenomegaly. Laboratory examination revealed the following data: hemoglobin 10.5 g/dl; white 
blood cells 6,500/mm
3; alkaline phosphatase 224 U; serum glutamic oxaloacetic transaminase 1,230 U; 
serum glutamic pyruvic transaminase 70 U; total bilirubin 215.3 μmol/l; direct bilirubin 169.4 μmol/l; 
total protein 56.6 g/l; albumin 26.2 g/l; prothrombin time 28.9 s. Ultrasonography of the abdomen 
showed coarse liver echotexture with an intrahepatic multicystic mass predominantly involving the left 
lobe of the liver and extending up to the porta hepatis. These channels were partly extrahepatic. The 
gallbladder, common bile duct and portal vein could not be identified separately. Splenomegaly, ascites 
and minimal right-sided pleural effusion were also noted on ultrasonography. Computed tomographic 
scan of the abdomen revealed moderately dilated central intrahepatic biliary radicals in the left Iobe. 
These radicals showed continuity with the extrahepatic cystic spaces. The common bile duct was not 
identifiable separately from these radicals. The kidneys were normal. A magnetic resonance 
cholangiopancreatography was performed which showed multiple intrahepatic and extrahepatic cysts 
without visualization of the common bile duct. Some of the biliary radicals noted at the periphery of the 
liver did not communicate with the dilated cystic lesion at the porta hepatis and produced distortion of 
the liver anatomy. This was interpreted as an manifestation of cystic change in a patient with biliary 
atresia. A color Doppler study of the heart rules out congenital cyanotic heart disease. Contrast-
enhanced echocardiography (using agitated saline injected in a peripheral vein) showed the appearance 
of contrast bubbles on the right side of the heart followed by the left side with a delay of 3 cardiac cycles, 
suggesting the presence of pulmonary arteriovenous fistulae. Liver biopsy and further surgical 
procedure were not possible because of refusal by the parents and due to poor prognosis. The child was 
treated using diuretics and multivitamins as recommended for a case of cholestasis. 
The Donor 
The living donor was his mother, a 26-year-old woman with blood group A, ABO identical to the 
patient. There was no biochemical or serologic evidence of liver disease for the donor. The hematologic, 
biochemical and urological analyses and the scintigraphic, radiologic and tomographic evaluations of 
the donor showed no abnormality. Accurate knowledge of the patient’s anatomy is essential to plan  
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subsequent steps for surgical anastomosis. Computed tomography with volumetric measurement was 
performed to assess the volume of the left lateral lobe in order to determine the graft to be harvested 
(fig. 1). Angiographic evaluation showed that the donor had little blood vessel variations. The left 
hepatic artery was derived from the right anterior hepatic artery, which was nearly inside the liver 
parenchyma (fig. 2). 
Donor Surgery 
An abdominal approach by bilateral subcostal incision was used with an upward midline extension 
to the xiphoid process. The falciform and left triangular ligaments, part accida and condensa of the 
gastrohepatic omentum were sectioned to mobilize the left liver. After dissecting the portal vascular 
pedicle and the left hepatic vein, intraoperative ultrasound was used to determine the configuration of 
the left hepatic vein, the junction of the middle hepatic vein with the left hepatic vein, and to mark on 
the liver surface the position of the middle hepatic vein, which would be the liver transection plane. The 
transection line was determined by the optimal graft volume and the anatomy of its drainage veins and 
marked with electrocautery on the liver surface. All of the right and left hepatic venous branches were 
traced to the periphery in the medial segment to confirm the distribution of these structures in the left 
lateral segment. Hilar dissection was performed to free the left hepatic artery and portal vein. The portal 
pedicle was identified with ultrasound guidance within the left lateral segment. Cholecystectomy was 
performed and the cystic duct was cannulated for cholangiography using undiluted radiographic 
contrast in order to delineate the ductal anatomy. The cholangiography showed that it had similar 
variation to the portal vein (fig. 3). Once the liver was mobilized, the left hepatic vein, left hepatic artery 
and left portal vein were isolated and the left hepatic duct was divided, the parenchyma was sectioned. 
With the use of the dissection and ligation technique, the left lateral lobe was detached well to the right 
of the attachment of the falciform ligament from the main part by intraoperative ultrasonography with 
an ultrasonic dissector, leaving the left portal vein, left hepatic artery and left hepatic vein intact. The 
dissection of the left hepatic artery was partly inside the liver parenchyma and the left duct was divided 
close to the cut surface of the liver, with an intact Glissonian sheath when the liver transection was 
finished. The left hepatic duct was divided near the confluence of the bile ducts. The left lateral 
bisegmental graft, consisting of the left lateral segment (LLS, segments II, III), was further reduced 
according to previous reports [6, 7]. The isolated graft was perfused in situ with the left portal vein 
clamped and cannulated by a catheter connected with cold lactated Ringer’s solution followed by a cold 
University of Wisconsin solution when the left hepatic vein was opened. The computed tomographic 
scan volume of the lateral segment was 297.198 cm
3. The weight of the implanted lateral segment was 
200 g, measured by fluid displacement. 
Recipient Surgery 
Hepatectomy was performed in a separate operating room. The abdomen was entered through a 
bilateral subcostal incision with midline extension. Hilar dissection was performed to isolate and divide 
branches of the hepatic artery and portal vein. It was laborious as a result of inflammation and fibrosis 
around the hepatoduodenal ligament. Some technical difficulties were encountered, including 
dissection of the portal vein and separation of the bile duct. After dissection and ligation of the hepatic 
arteries, the portal vein and bile duct were clamped en masse. Just before the recipient hepatectomy, the 
donor graft was removed and the portal vein and hepatic artery perfused with cold University of 
Wisconsin solution. The left suprahepatic vein was implanted in a new ostium on the anterolateral 
surface of the vena cava using the ostium of the right suprahepatic vein as one of the sides of this 
triangular orifice with a 4–0 continuous prolene suture. The ostium of the donor suprahepatic vein was 
sectioned as close to the hepatic parenchyma as possible to avoid outfow problems. The openings in the 
middle and left suprahepatic veins were closed. Portal reconstruction was performed by end-to-end 
anastomosis to the truncated bifurcation of the recipient portal vein with a 6–0 prolene suture. Once 
completed, the hepatic artery was reconstructed to the recipient hepatic artery using microvascular 
techniques with the aid of microscopy (original magnification ×310) using a 7–0 prolene suture. A short 
interposition vein graft from the donor liver was inserted. The great saphenous vein was harvested from 
the donor for a length of 5 cm in a standard fashion noting the direction of flow, which can prove 
life-saving under these circumstances. The graft was then revascularized, and hemostasis was 
performed. The total ischemic time was 3 h 20 min. The transplanted liver started to function after 
completion of portal vein anastomosis followed by hepatic artery reconstruction. Intraoperative color 
flow Doppler ultrasound was performed to demonstrate vascular flow patterns, pulsatility and velocities 
after vessel reconstruction, before and after abdominal closure for early detection of possible vascular 
complications. The falciform ligament was reconstructed in left-side grafts. Extreme care to prevent air  
Case Rep Gastroenterol 2010;4:158–167 
DOI: 10.1159/000314195 
Published online: May 12, 2010  © 2010 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
161
and particulate embolism in the cava was done by flushing the graft with lactated Ringer’s solution 
before completion of hepatic vein and portal anastomoses. Biliary reconstruction was performed with 
interrupted polypropylene 7–0 sutures with extramucosal knots. The left hepatic duct was anastomosed 
end-to-side to the Roux-en-Y loop of jejunum with an internal stent after the hepatic artery 
anastomosis. After securing hemostasis, both the donor and the recipient abdomens were closed by 
placing a closed suction drain in the retroperitoneal space for each patient. The donor received 3 U 
blood, and the recipient received 6 U during the procedure. Table 1 summarizes recipient and donor 
parameters. 
Immunosuppression and Follow-Up 
Postoperative immunosuppression consisted of azathioprine (2 mg/kg/day i.v.), prednisolone 
(2.5 mg/kg/day i.v.) and cyclosporine. Cyclosporine is administered orally one day after transplantation 
at a dose of 3 mg/kg/day divided into two doses, except for cases with hepatic encephalopathy and 
severe infection. The target posttransplantation whole blood trough concentration of cyclosporine was 
250–350 ng/ml during the first 3 months and around 150–250 ng/ml thereafter. Steroids were started on 
graft reperfusion at a dose of 10 mg/kg and then gradually reduced from 1 mg/kg/day to 0.3 mg/kg/day 
over the first month. The child began to recover after surgery. The postoperative day was uneventful. 
There was no steroid-resistant rejection or chronic rejection. Similarly, there were no obvious 
postoperative complications. Persistent arterial hypertension requiring medication was not seen in this 
recipient. Liver function improved persistently (table 2). There were no significant differences in the 
preoperative and 6-month postoperative levels of cholesterol, triglyceride, uric acid, and fasting blood 
glucose. Height and weight greatly improved after operation. The postoperative course of the donor was 
uneventful. A slight elevation of bilirubin (total 4.3 mg; direct 2.3 mg) occurred during the first 48 h, but 
returned to normal within a couple of days, and she was ready to be discharged on the seventh 
postoperative day. Three months after surgery, she began to work as laboriously as before the operation 
and is still doing well. 
Discussion 
Biliary atresia continues to be the most frequent indication in children or infants for 
liver transplantation. Liver transplantation in infants represents a major medical and 
technical challenge, particularly in babies weighing <5 kg [1, 8]. Before 1990, the absence 
of appropriate full-sized grafts and the technical difficulties encountered in learning to 
reduce larger livers led to poor outcomes in infants less than 1 year of age. Small 
recipients less than 1 year of age or weighing <5 kg are typically prone to complications 
with a one-year survival of 64%, compared with 75% of older pediatric recipients [9, 10]. 
This is consistent with the results from our institution, which demonstrate a 20% graft 
survival and 25% patient survival in transplants done prior to 2008 in infants <5 kg. 
Retransplantation was common, predominately for vascular complications with portal 
vein thrombosis and primary nonfunction occurring more frequently in the younger age 
groups, which frequently led to loss of graft and death of the patient; the mortality rate 
was approximately 50%. Liver transplantation was not considered by some groups in 
infants weighing <3 kg [11]. The explanation for this was mainly anatomical. For 
example, the calibre discrepancy of the graft and recipient hepatic artery understandably 
leads to a higher incidence of vascular complications [12]. Mazzaferro et al. [13] suggested 
that arteries <3 mm are at an increased risk of thrombosis, in a 2 mm or less vessel for the 
left lateral segment graft. Even the use of a microscope would not ameliorate the increased 
risk of thrombosis in this situation, but recipient age is not a factor in hepatic artery 
thrombosis. With the development of reduction hepatectomy, but also with advances in 
medical and nursing expertise, weight alone (<7 kg) should not be considered a 
contraindication for liver transplantation [9]. Liver transplantation in infants weighing 
<7 kg is technically demanding but feasible and can still be performed with good outcome 
[14]. Some groups have reported their experience with liver transplantation in infants  
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during the first 3 months of life, with a mean weight at the time of transplantation of 3.4 ± 
1 kg [15]. Our patient was weighing <5 kg at the time of transplantation and had not 
previously undergone hepatic portoenterostomy (Kasai procedure). 
The size of the donor is an important consideration, since in a small child it is 
important to avoid a large-for-size graft, which is associated with complications. A 
graft-to-recipient weight ratio of more than 5% constitutes a large-for-size graft [16]. This 
may cause a reduced vascular inflow, which may be further compounded by compression 
of the graft and vessels by a tight abdominal closure. Surgical techniques must be adapted 
for adequate graft preparation, vascular reconstruction and abdominal closure [16–19]. 
The Kyoto group reported monosegmental graft transplantation. This group has recently 
published their experience in vascular reconstruction in infants weighing <6 kg, reporting 
a low incidence of hepatic outflow complications (1.5%) and a portal vein and hepatic 
artery complication rate of 14 and 7.7%, respectively [20]. In our patient, the mean weight 
ratio between donor and recipient was 5.025. It is important to avoid compression of the 
graft or right lung, and temporary abdominal closure (using a silastic patch if necessary) 
is advisable in cases where there is any degree of tightness. Tailoring graft size to the size 
of the recipient is paramount in pediatric liver transplantation. The reduced left lateral 
segment technique used in this procedure is a safe and useful alternative to 
monosegmental liver transplantation. This technique has been developed to provide a 
transplanted liver graft of sufficient parenchymal mass, whilst limiting the potentially 
serious problems of a large-for-size graft in a small recipient, i.e. insufficient blood flow to 
the revascularized liver and too tight an abdominal closure, which may cause graft 
compression, or the need for prosthetic abdominal wall closure. We have found that the 
technique is safe and does not compromize the vascular supply and drainage of the liver 
graft [6]. We have not experienced problems with delayed closure and have not seen an 
increase in wound infection in these patients for using a reduced left lateral segment liver 
graft, in common with other authors [6–8]. This patient, when staying in the pediatric 
intensive care unit after liver transplantation, was also intraabdominal pressure-
monitored by direct and indirect methods, especially if mechanically ventilated. 
As published in other studies, infectious complications average around 65% of 
patients and result in mortality in >50% of patients [21, 22]. In common with our 
previous data, infection was a major problem in 10 (62%) of our previous patients [22]. 
Sepsis was the most frequent infection, affecting 5 (31%) of the infants but causing no 
deaths. Cytomegalovirus and Adenovirus have been implicated as the leading viral cause 
of morbidity and mortality in children [23]. This patient had a prolonged and 
complicated hospital course with Cytomegalovirus positivity, but was treated successfully 
with cidofovir and discharged home. Standard treatment with minimization of 
immunosuppression, ganciclovir or acyclovir, and intravenous immunoglobulin has not 
demonstrated consistent success. 
With the increasing availability of living donors, many centers have now published 
their experience with improved techniques for liver grafts from living donors also 
showing good results [24–26]. Liver transplantation for infants weighing <5 kg can be 
technically challenging but can have equivalent graft and patient survival when compared 
to larger children requiring liver transplantation. The significant improvement of survival 
for liver transplantation with infants weighing <5 kg through surgical technique 
improvement was similar to that of infants >5 kg. The infant described here is recognized 
as the youngest liver transplantation recipient in China. Infants should not be denied liver 
transplantation based on weight alone.  
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Table 1. Summary of recipient and donor operative variables 
Total operative time, min  552 
Cold ischemia, min  60 
Warm ischemia, min  32 
Blood type combinations (D-R)  A-A 
Graft weight, g  200 
Graft/recipient ratio, %  5.025 
Venous graft (length), cm  4 
Blood loss, ml  260 
Packed red cell transfusion, ml  100 
 
 
Table 2. Preoperative and postoperative summary of liver function in the recipient 
  15 days after 
transplantation 
5 days after 
transplantation 
On 
admission 
Total bilirubin (2.0–20), μmol/l   17.2   56.6   215.3 
Direct bilirubin (0–4), μmol/l  6.9   36.5  169.4 
Alkaline phosphatase (0–20), U/l  74   94  224 
Gamma glutamyl transferase (0–50), U/l  85   79  162 
Albumin (33–52), g/l  32.9   28.9  26.2 
Prothrombin time (9–16), s  14   17  28.9 
APTT (28–39), s  36   46  66 
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Fig. 1. The liver parenchyma was excised well to the right of the attachment of the falciform ligament. 
 
 
 
Fig. 2. Donor hepatic angiogram showing normal arterial structure. 
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Fig. 3. Cholangiography of the donor. Two branches of right bile duct (anterior and posterior right bile 
ducts) of the mother. 
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